How does aurobindo verify clonazepam tablets dissolution rate?

How does Aurobindo test dissolution for clonazepam tablets?

Aurobindo performs dissolution testing on clonazepam tablets using the USP <711> apparatus 2 (paddle) method at 75 rpm with 900 mL of water as the medium. The sampling times are 5, 10, 15, 30, 45, and 60 minutes. They measure the amount released at each time point by UV spectrophotometry at 247 nm. The specification requires at least 80% of the labeled amount dissolved in 30 minutes.

How does Aurobindo compare its dissolution data with other manufacturers?

Aurobindo submits its dissolution profiles to the FDA for bioequivalence demonstration. The company uses f2 similarity factor calculations to show that its tablets release clonazepam in a similar way to the reference listed drug. The f2 score must exceed 85 to passing criteria for generic approval. Aurobindo also keeps internal records of lot-to-lot consistency.

When can biosimilars or generics compete with Aurobindo’s clonazepam?

Aurobindo’s clonazepam tablets are fully generic. No further patent or exclusivity period blocks new entrants. New manufacturers enter by filing an ANDA with matching dissolution specifications. Matching the USP monograph limits and f2 similarity scores with the RLD is required for approval.

What happens if Aurobindo’s clonazepam tablets fail dissolution specifications?

Aurobindo’s tablets fail if less than 80% dissolves in 30 minutes. The company investigates root causes such<|eos|>